A Șerban

469 total citations
27 papers, 216 citations indexed

About

A Șerban is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Șerban has authored 27 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Șerban's work include Pituitary Gland Disorders and Treatments (16 papers), Adrenal Hormones and Disorders (8 papers) and Adrenal and Paraganglionic Tumors (7 papers). A Șerban is often cited by papers focused on Pituitary Gland Disorders and Treatments (16 papers), Adrenal Hormones and Disorders (8 papers) and Adrenal and Paraganglionic Tumors (7 papers). A Șerban collaborates with scholars based in Italy, Romania and United States. A Șerban's co-authors include Emanuele Ferrante, Maura Arosio, Giovanna Mantovani, Giulia Carosi, Rita Indirli, Marco Locatelli, Claudia Giavoli, Elisa Sala, Giulia Rodari and Eriselda Profka and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of neurosurgery and Annals of Oncology.

In The Last Decade

A Șerban

24 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Șerban Italy 10 160 62 41 24 24 27 216
Giulia Carosi Italy 14 261 1.6× 110 1.8× 37 0.9× 34 1.4× 17 0.7× 30 331
Emmanuelle Proust-Lemoine France 7 190 1.2× 15 0.2× 31 0.8× 25 1.0× 11 0.5× 18 263
Irene Gagliardi Italy 9 99 0.6× 39 0.6× 22 0.5× 22 0.9× 13 0.5× 25 195
Julie Lynch United Kingdom 7 136 0.8× 34 0.5× 26 0.6× 27 1.1× 23 1.0× 17 187
Elizaveta Orlova Russia 7 176 1.1× 21 0.3× 40 1.0× 27 1.1× 6 0.3× 31 245
H Ythier France 8 82 0.5× 76 1.2× 12 0.3× 96 4.0× 69 2.9× 23 280
Patinut Buranasupkajorn Thailand 9 91 0.6× 60 1.0× 8 0.2× 58 2.4× 8 0.3× 19 222
P Thiéblot France 6 163 1.0× 107 1.7× 23 0.6× 20 0.8× 10 0.4× 27 250
Maria Kareva Russia 6 144 0.9× 22 0.4× 32 0.8× 39 1.6× 8 0.3× 45 201
Irene Hadjidemetriou United Kingdom 6 90 0.6× 51 0.8× 11 0.3× 79 3.3× 8 0.3× 9 179

Countries citing papers authored by A Șerban

Since Specialization
Citations

This map shows the geographic impact of A Șerban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Șerban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Șerban more than expected).

Fields of papers citing papers by A Șerban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Șerban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Șerban. The network helps show where A Șerban may publish in the future.

Co-authorship network of co-authors of A Șerban

This figure shows the co-authorship network connecting the top 25 collaborators of A Șerban. A scholar is included among the top collaborators of A Șerban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Șerban. A Șerban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Șerban, A, Benedetta Zampetti, Andrea Saladino, et al.. (2023). Case Report: Opposite Tumoral and Hormonal Responses to Low-dosePasireotide in Cushing’s Disease. Endocrine Metabolic & Immune Disorders - Drug Targets. 24(7). 845–849.
2.
Sala, Elisa, Giulia Carosi, A Șerban, et al.. (2021). Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience. Journal of Endocrinological Investigation. 44(12). 2593–2599. 2 indexed citations
3.
Șerban, A, Lorenzo Rosso, Paolo Mendogni, et al.. (2021). Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome. Frontiers in Endocrinology. 12. 687539–687539. 4 indexed citations
4.
Ferrante, Emanuele, A Șerban, Rita Indirli, et al.. (2021). Usefulness of non-stimulated copeptin in the diagnosis of diabetes insipidus after pituitary surgery. Journal of Endocrinological Investigation. 44(10). 2315–2317. 3 indexed citations
5.
Indirli, Rita, Elisa Sala, A Șerban, et al.. (2021). Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis. Frontiers in Endocrinology. 12. 689887–689887. 10 indexed citations
6.
Ferrante, Emanuele, A Șerban, Marigrazia Clerici, et al.. (2021). Evaluation of procoagulant imbalance in Cushing’s syndrome after short- and long-term remission of disease. Journal of Endocrinological Investigation. 45(1). 9–16. 6 indexed citations
7.
Ferrante, Emanuele, Mattia Barbot, A Șerban, et al.. (2021). Indication to dynamic and invasive testing in Cushing’s disease according to different neuroradiological findings. Journal of Endocrinological Investigation. 45(3). 629–637. 16 indexed citations
8.
Treppiedi, Donatella, Giusy Marra, Anna Maria Barbieri, et al.. (2021). USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs. Endocrine Related Cancer. 28(8). 573–582. 14 indexed citations
9.
Indirli, Rita, Emanuele Ferrante, Erica Scalambrino, et al.. (2020). Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry. The Journal of Clinical Endocrinology & Metabolism. 106(4). 1660–1672. 13 indexed citations
10.
Șerban, A, Emanuele Ferrante, Giulia Carosi, et al.. (2020). COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy. Journal of Endocrinological Investigation. 44(6). 1335–1336. 22 indexed citations
11.
Carosi, Giulia, Valentina Morelli, A Șerban, et al.. (2020). Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Centre. SSRN Electronic Journal. 2 indexed citations
12.
Carosi, Giulia, Valentina Morelli, A Șerban, et al.. (2020). Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center. The Journal of Clinical Endocrinology & Metabolism. 106(3). e1354–e1361. 30 indexed citations
13.
Catalano, Rosa, Elena Giardino, Donatella Treppiedi, et al.. (2020). The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. Cancer Letters. 497. 77–88. 8 indexed citations
14.
Șerban, A, Elisa Sala, Giulia Carosi, et al.. (2019). Recovery of Adrenal Function after Pituitary Surgery in Patients with Cushing Disease: Persistent Remission or Recurrence?. Neuroendocrinology. 108(3). 211–218. 13 indexed citations
15.
Șerban, A, Elisa Sala, Giulia Carosi, et al.. (2019). Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series. Journal of Endocrinological Investigation. 43(5). 631–639. 13 indexed citations
16.
17.
Buraga, Ioan, et al.. (2015). Multiple sclerosis: varied symptoms, one disease. Journal of the Neurological Sciences. 357. e298–e298.
18.
Șerban, A, et al.. (2003). Prise en charge de l'enfant et de l'adolescent obèses. Annales d Endocrinologie. 64(5). 1 indexed citations
19.
l’Allemand, Dagmar, Elisabeth Keller, Wolfgang Hoeppner, et al.. (1996). Nonclassical adrenal hyperplasia due to 21-hydroxylase-deficiency: Does genotyping predict the clinical manifestation?. Endocrine Research. 22(4). 735–739. 1 indexed citations
20.
Șerban, A, et al.. (1960). [Considerations on ovarian changes in the congenital adrenogenital syndrome].. PubMed. 36. 1144–52/SP. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Carosi Breakdown of academic impact, for papers by Emmanuelle Proust-Lemoine Breakdown of academic impact, for papers by Irene Gagliardi Breakdown of academic impact, for papers by Julie Lynch Breakdown of academic impact, for papers by Elizaveta Orlova Breakdown of academic impact, for papers by H Ythier Breakdown of academic impact, for papers by Patinut Buranasupkajorn Breakdown of academic impact, for papers by P Thiéblot Breakdown of academic impact, for papers by Maria Kareva Breakdown of academic impact, for papers by Irene Hadjidemetriou
Rankless by CCL
2026